By Sanius Health
Now entering its third year, the Haematology Patient & Carers Congress (HPCC26) and the Clinical Research Forum (CRF26), created and delivered by Sanius Health, have become Europe’s largest events of their kind. Together they draw thousands of participants – senior doctors, patients, policymakers, industry partners, and innovators – for a high-energy journey from big ideas to real-world breakthroughs.
Sanius Health has announced that Sir Jim Mackey, Chief Executive of NHS England, will headline HPCC26 and CRF26 in May 2026. His participation marks a defining moment for these flagship congresses, which stand as the most influential global platforms dedicated to advancing care, research, and innovation for patients with haematological, rare, and chronic conditions.
Sir Jim Mackey is among the most respected leaders in UK healthcare, recognised for his patient-centred reforms, commitment to service improvement, and leadership in strengthening NHS performance during times of profound change. As Chief Executive, he oversees the strategic direction of the NHS, guiding it to deliver world-class care while navigating increasing demand and rapid clinical and digital innovation. His keynote at HPCC26 × CRF26 will highlight the urgent need to embed value-based care, expand equitable access to new therapies and technologies, and design future models of care that meet the needs of diverse populations across the UK and beyond.
Equity, Access, and Transformation at Scale
Together, HPCC26 and CRF26 form a dual platform unmatched in ambition. They unite the patient voice, clinical expertise, research innovation, and system leadership to transform outcomes in blood disorders and haemato-oncology. HPCC26 is the leading patient-centred congress in the field, while CRF26 serves as the premier global forum for Key Opinion Leaders, clinical researchers, and industry innovators advancing the future of blood cancer research and care.
In May 2026, the combined congress will welcome thousands of patients, clinicians, NHS executives, and leaders from academia, advocacy, biotech, and pharma. This unparalleled participation creates a rare environment where lived experience converges with system design, scientific progress, and policy ambition.
When System Leadership Meets Global Innovation
The involvement of NHS England’s senior leadership alongside global scientific and industry figures underscores the strategic importance of HPCC26 × CRF26. By convening those who set national policy with those pioneering scientific and clinical breakthroughs, the congresses ensure that conversations translate into tangible change across care models, access strategies, and research priorities.
A Defining Moment for the Community
The dual convening of HPCC26 and CRF26 represents an unprecedented opportunity for the haematology, haemato-oncology, and rare disease community. Sir Jim Mackey’s headline keynote signals the ambition of this year’s programme and reflects Sanius Health’s commitment to delivering platforms that drive equity, access, and innovation at scale.
From Vision to Reality: The Future of Care is Here
Expected to be the most ambitious edition yet, HPCC26 × CRF26 will unite more than 2,000 patients, 300+ clinicians, 300+ hospitals, and 100+ NHS executives. By spotlighting lived experience alongside cutting-edge research, and with Sir Jim Mackey anchoring the programme, the congresses will play a central role in shaping a more equitable, innovative, and patient-centred future.
Get Involved
For partnership opportunities or programme updates, contact info@saniushealth.com.
Event websites: www.hpccevent.com | www.crfevent.com
